Samsara Therapeutics
Biotechnology company discovering novel biology via its platform for identifying autophagy enhancers, leveraging it towards developing breakthrough medicines for age-related diseases and areas of high unmet need.
Notes
Samsara Therapeutics is a biotechnology company focused on discovering and developing autophagy-enhancing therapeutics. The company's proprietary platform enables the identification of novel autophagy enhancers that can be developed into breakthrough medicines for age-related diseases and other areas of high unmet medical need.
Autophagy is the cellular process by which cells clean up damaged proteins and organelles. Enhancing autophagy has been shown to have beneficial effects on aging and age-related diseases in preclinical models. Samsara is working to translate these findings into human therapeutics.
The company is backed by Apollo Health Ventures, which focuses on longevity and aging-related biotechnology.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Autophagy enhancer discovery platform
- Backed by Apollo Health Ventures
- Focus on breakthrough medicines for age-related diseases
- Oxford, UK headquarters
- Part of the growing longevity biotech ecosystem
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |